Winthrop Partners - WNY’s iShares iBonds Dec 2032 Term Corporate ETF IBDX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.22M Buy
88,182
+13,134
+18% +$331K 1.1% 33
2026
Q1
$1.9M Buy
75,048
+25,360
+51% +$647K 1.01% 34
2025
Q4
$1.27M Buy
+49,688
New +$1.27M 0.68% 39

Other funds holding IBDX

Winthrop Partners - WNY's IBDX Position: Q2 2026 in Review

Winthrop Partners - WNY increased its iShares iBonds Dec 2032 Term Corporate ETF (IBDX) stake by 18% in Q2 2026, buying an estimated $331K and bringing the position to 88,182 shares worth $2.22M. The position accounts for 1.1% of the portfolio, ranked #33.

Winthrop Partners - WNY first reported a position in IBDX in Q4 2025 and has held it in 3 quarters since. 228 funds tracked by Wall St. Rank hold IBDX as of Q2 2026.

  • Winthrop Partners - WNY held 88,182 shares of iShares iBonds Dec 2032 Term Corporate ETF worth $2.22M as of Q2 2026.
  • Winthrop Partners - WNY bought 13,134 iShares iBonds Dec 2032 Term Corporate ETF shares in Q2 2026, an estimated $331K.
  • iShares iBonds Dec 2032 Term Corporate ETF made up 1.1% of Winthrop Partners - WNY's portfolio in Q2 2026, its #33 holding.
  • Winthrop Partners - WNY first reported a position in iShares iBonds Dec 2032 Term Corporate ETF in Q4 2025 and has held it in 3 quarters since.
  • 228 funds tracked by Wall St. Rank held iShares iBonds Dec 2032 Term Corporate ETF as of Q2 2026.

Based on Winthrop Partners - WNY's 13F filing for Q2 2026, filed 15 Jul 2026.